Confideo’s Post

Leading the Way in Adherence Insights: The Unrivaled Success of Information Mediary Corp Since its inception over two decades ago, Information Mediary Corp (IMC) has meticulously built a multi-disciplinary team with a singular focus: to bridge diverse industries and deliver the most advanced smart blister solution to the market. The driving force behind our journey has always been to be the absolute best in this field, and the result has been beyond our expectations. To our own surprise, and the surprise of many, the Med-ic smart blister has emerged as the ONLY viable smart blister solution that is widely used in large clinical trials. This unprecedented success has solidified our position as trailblazers in the industry, showcasing the efficacy, reliability, and unparalleled performance of our innovative solutions. As we reflect on this remarkable milestone, we remain steadfast in our commitment to pushing the boundaries of pharmaceutical research and delivering solutions that stand as the pinnacle of excellence. The unwavering dedication of our multi-disciplinary team continues to drive the success of the Med-ic smart blister, reinforcing our status as the unrivaled leader in pioneering smart blister technology. As we celebrate this achievement, we extend our gratitude to our partners, clients, and collaborators who have placed their trust in us. Together, we have helped change the landscape of pharmaceutical research, setting new standards of excellence and ushering in a new era of innovation. Looking ahead, we remain resolute in our mission to continue shaping the future of patient care, pioneering groundbreaking solutions, and cementing Information Mediary Corp as the unrivaled leader in the pharmaceutical research domain. With the Med-ic smart blister, we have set a new benchmark for excellence, and we are committed to surpassing it with each new iteration. Thank you for joining us on this extraordinary journey, and we look forward to shaping the future of pharmaceutical research together. The best is yet to come. #medicationadherence #clinicaltrials #clinicalresearch #smartpackaging #remotetrials #mems #ecap #certiscan #cmoinsights

The ONLY viable smart blister solution that is widely used in large clinical trials.

A new journey will start!!

Rescue Mission in Biopharma: When you need to be rescued, call them. Don’t bother for the run of the mill services. Let all other service providers— internally & externally alike— fail and give up. Then, Global Allied pharmaceuticals(GAP via www.TakeChargeMedical.com)manages to fix it. From Article 21 to the CIA violations; from the known cases of study holds, to regulatory recall’s with 483, etc. have been managed. GAP is a supreme solution provider with precision, accuracy & the structured proven track record in biopharma and devices. GAP offers a known and commanded authority, as well as a sustained value net in this space.

Despite substantial investment, the #pharma industry has yet to fully benefit from digital #HCP engagement strategies due to a lack of coordination with personal, face-to-face channels. In this live webinar, #IQVIA’s Antonio Pregueiro and Matthew Smith are joined by leading commercial industry experts from Gilead Sciences and Regeneron, and will discuss how to properly embrace new technologies as the solution: https://bit.ly/45Zrs7D

How can you mitigate challenges that arise in your ophthalmic drug development program? By partnering with Altasciences, an integrated CRO/CDMO. We can safely advance your product seamlessly through each development phase with accelerated timelines and cost savings, ease of data transfer, reduced handoffs, and fewer logistical challenges. Learn how our end-to-end ophthalmic drug development solutions optimize your program and get your products to market, faster: https://lnkd.in/dfaXBFeN

It's early in 2024 and we're already witnessing some major changes in the BioPharma Industry. Our own CEO, Cory Lewis, provides his three key trends that will shape the CDMO industry in 2024. See article here: https://lnkd.in/gaWJXTc4 What other changes or trends do you see coming?

Pharma CDMO industry is changing fast! And leading companies who see the right trends can capitalize on this change by capturing higher market share, while getting better at operational efficiency & customer-centricity! Nice article below on some of the key trends! I liked the “CdMO” term coined as “Customer-driven Manufacturing Organization”!

Thoughts on this? >> Weeks after closing Bristol Myers deal, Karuna's ex-CEO heads to Blackstone-backed Anthos >> Comment below! >>> lqventures.com #strategy #competitiveintelligence #marketing #productmarketing #pharmaceutical #healthcare #pharma #biotech

Thoughts on this? >> Weeks after closing Bristol Myers deal, Karuna's ex-CEO heads to Blackstone-backed Anthos >> Comment below! >>> lqventures.com #strategy #competitiveintelligence #marketing #productmarketing #pharmaceutical #biotech #pharma #healthcare